{"id":"W4379741884","doi":"10.1016/j.jtho.2023.05.021","title":"Early Circulating Tumor DNA Dynamics and Efficacy of Lorlatinib in Patients With Treatment-Naive, Advanced, ALK-Positive NSCLC","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Universitair Medisch Centrum Groningen; Yuhan; BeiGene; Chugai Pharmaceutical; CMC Microsystems; Amgen; Pfizer; AstraZeneca; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Crizotinib; Medicine; Hazard ratio; Internal medicine; Confidence interval; Biomarker; Oncology; Tyrosine-kinase inhibitor; Progression-free survival; Gastroenterology; Overall survival; Cancer; Lung cancer; Genetics; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000150778,0.0001234574,0.0003171608,0.000128477,0.00003074616,0.000008653378,0.00008539627,0.00008607307,0.000002346111],"category_scores_gemma":[0.0001186212,0.0001029171,0.00006318797,0.0001535088,0.00008000439,0.00000779219,0.00005560657,0.00009621699,8.514129e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001349194,"about_ca_system_score_gemma":0.0002015783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002116819,"about_ca_topic_score_gemma":0.00009271759,"domain_scores_codex":[0.9991278,0.00006189907,0.0003694686,0.0001607212,0.00009879237,0.0001813306],"domain_scores_gemma":[0.9990487,0.0001303676,0.0004587378,0.0001169017,0.0001707698,0.00007457395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007310462,0.000934381,0.5146347,0.00005379552,0.0003621841,0.0002582462,0.001029692,0.003485866,0.02377752,0.00008839663,0.0000715545,0.4479932],"study_design_scores_gemma":[0.004960975,0.009581125,0.9769759,0.0001237181,0.0001157401,0.00005777743,0.0003483749,0.0003040161,0.006770616,0.00007601624,0.0004926789,0.0001930592],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988976,0.0001747916,0.000101817,0.00009826687,0.0001384193,0.0001736335,0.00004743229,0.000002225066,0.0003658308],"genre_scores_gemma":[0.9985428,0.0001416314,0.001089576,0.00004644613,0.00008262307,0.000003394686,0.00004038043,0.00001788102,0.00003527993],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4623412,"threshold_uncertainty_score":0.4196838,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007478386264094088,"score_gpt":0.3143189457278874,"score_spread":0.3068405594637933,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}